Fresenius Finance Ireland PLC EO-Med.-Term Nts 2021(28/28)
Type of financial instrument
Corporate Bond
Sub-Type
Financial
Yield
3.19
Yield spread Bundesanleihe
0.6239
Tradable for private investors
Yes
Minimum amount tradeable unit
1,000.00
Maturity
01/10/2028
Interest Rate
0.50 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 94.062 G / 3.19 | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:47:25 PM | |
| DAILY VOLUME (NOMINAL) | 5,000 | |
| YIELD SPREAD | 0.6239 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 94.345 | 94.062 |
| PREV. DAY'S PRICE | 94.165 | (06/02) |
| CHANGE DAY BEFORE | -0.10 | -0.11 % |
| 52 WEEK HIGH / LOW | 94.837 (02/27) | 92.412 (03/23) |
Master Data
| WKN | A3KN0S |
| ISIN | XS2325565104 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Financial |
| ISSUER | Fresenius Finance Ireland PLC |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 0.50 % |
| INTEREST RUN FROM | 01/04/2021 |
| NEXT INTEREST PAYMENT | 01/10/2026 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.341 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 500.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 1,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 01/10/2028 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create an account here.
Company profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.